Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Cetuximab

Non-healing corneal erosion treated with epidermal growth factor: case report

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Foerster CG, Cursiefen C, Kruse FE.Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody). Cornea 27: 612-614, No. 5, Jun 2008 - Germany

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Cetuximab. React. Wkly. 1209, 11 (2008). https://doi.org/10.2165/00128415-200812090-00033

    Download citation

    Keywords

    • Public Health
    • Patient Outcome
    • Congenital Anomaly
    • Cetuximab
    • Actual Body